This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Palatin Technologies Inc PTN
$6.89
▼ -4.70%
($-0.34)
🎈 Low Float
📅 Earnings This Week
Open
$6.89
Prev Close
$7.23
Day Range
$6.70 – $7.15
52W Range
$4.51 – $31.00
Market Cap
$12.88M
Beta
0.94
EPS (TTM)
$-0.08
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 1999-12-21 |
| Shares Out. | 1,780,000 |
| Website | palatin.com ↗ |
| Phone | 16094952200 |
| Employees | 25 |
| Revenue | $300,770 |
| Gross Profit | $300,770 |
| Net Income | -$4.4M |
| Free Cash Flow | -$13.6M |
| Total Assets | $8.5M |
| Total Liabilities | $1.8M |
| Equity | $6.7M |
About Palatin Technologies Inc
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.
Palatin Technologies Inc is a publicly traded company under the ticker symbol PTN on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-11-01)